Rising Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RISING PHARMS, and what generic and branded alternatives to RISING PHARMS drugs are available?
RISING PHARMS has one approved drug.
Summary for Rising Pharms
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Rising Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising Pharms | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 204928-001 | Aug 25, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Rising Pharms | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 204928-002 | Aug 25, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
